Human Genome Holder Says Glaxo Bid "Unacceptable" - Newspaper

Date : 04/29/2012 @ 9:37AM
Source : Dow Jones News
Stock : Human Genome Sciences, Inc. (MM) (HGSI)
Quote : 14.24  0.0 (0.00%) @ 2:05AM

Human Genome Holder Says Glaxo Bid "Unacceptable" - Newspaper

Human Genome Sciences (NASDAQ:HGSI)
Historical Stock Chart

5 Years : From Oct 2012 to Oct 2017

Click Here for more Human Genome Sciences Charts.

A fund with a 5.6% stake in Human Genome Sciences Inc. (HGSI), the U.S. drug company for which GlaxoSmithKline PLC (GSK.LN) has made an unsolicited $2.6 billion offer, said the approach is "unacceptable", according to the Sunday Times.

Human Genome Sciences, based in Rockville, Md., on April 20 rejected Glaxo's $13 a share offer, which it said undervalues the company.

Taube Hodson Stonex, a London-based fund, said the offer amounted to Glaxo trying to "get a steal with an offer that completely undervalues the company", the Sunday Times reports, attributing the remarks to Taube Hodson Stonex's Mark Evans.

"Towards $20 per share would still feel undervalued," Evans is quoted as saying.

THS couldn't be reached for comment Sunday.

Glaxo and Human Genome Sciences have a long working relationship, co-leveloping and sharing profits on Benlysta, a lupus medicine.

Newspaper Web site:

-London Bureau, Dow Jones Newswires; +44 (0)20 7842 9320

Latest HGSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.